92 Followers on Owler

Insmed

is a New Jersey-based biopharmaceutical company that develops and commercializes novel therapies for the treatment of lung and inflammatory diseases... Read more
OverviewCompetitorsAcquisitionsFundingNews & Insights

Insmed

is a New Jersey-based biopharmaceutical company that develops and commercializes novel therapies for the treatment of lung and inflammatory diseases... Read more
Insmed Chairman & CEO: William H. Lewis

Chairman & CEO

William H. Lewis

CEO Approval Rating

89/100

1988

PublicIndependent CompanyNASDAQINSM

Pharmaceuticals & Biotechnology
PharmaceuticalsBiotechnology
2834 NAICS listing

Annual Revenue
$363.7M
Employees
740
Funding
$1.8B
Acquisitions
1

News

Conference Presentation
Feb 11, 2025
Yahoo
Insmed To Present at March 2025 Investor Conferences
Funding
Nov 14, 2024
Global Legal Chronicle
Insmed received $150M in Post-IPO Debt Funding

Insmed Competitors

1Arcutis
2Vyome Therapeutics
3Edesa
4Thetis
5Laurent Pharmaceuticals
6Taiwan Liposome Company, Ltd.
7Strongbridge Biopharma
8Flexion
9Dicerna
10Heron
Unlock 24 + competitors

Trending Companies